false
OasisLMS
Login
Catalog
SHM Converge Scientific Abstract ePoster Gallery
Periprocedural Intracranial Hemorrhage: A Review o ...
Periprocedural Intracranial Hemorrhage: A Review of Beta-Blocker Withdrawal
Back to course
Pdf Summary
This case report describes a 77-year-old woman with hypertension on metoprolol and stage IV uterine carcinosarcoma who developed a severe headache and acute intracranial hemorrhage about four hours after an endoscopy performed for acute anemia. Her home beta-blocker was held peri-procedurally because of concern for GI bleeding. The authors argue that this likely caused rebound tachycardia and hypertension, contributing to increased intracranial pressure and hemorrhage in the setting of a brain metastasis.<br /><br />On presentation, she had no focal neurologic deficits and was found to have marked metabolic and inflammatory abnormalities, including thrombocytopenia, renal dysfunction, hyponatremia, and elevated bilirubin and creatine kinase. CT of the head showed a left frontal lobe mass with central acute hemorrhage, mild mass effect, and vasogenic edema. She was treated with steroids and transferred to neuro-critical care. Follow-up imaging showed stable hemorrhage without progression. Her antihypertensive medications were restarted and adjusted, and she was discharged to pursue stereotactic radiotherapy. She later returned with respiratory failure from lung metastases and transitioned to comfort-focused care.<br /><br />The discussion reviews evidence on peri-procedural beta-blocker management. Continuing beta-blockers is generally associated with fewer cardiovascular events and lower mortality after noncardiac procedures, though it may increase vasopressor use and PACU stay. In contrast, beta-blocker withdrawal has been linked to rebound sympathetic activation, cardiovascular complications, and increased mortality. The authors note that metoprolol has been associated in some studies with perioperative stroke and hypotension, though this has not been consistently shown for other beta-blockers. The report emphasizes the need for individualized risk-benefit assessment when deciding whether to continue beta-blockers around procedures.
Asset Subtitle
Aaron Z. Reyes
Meta Tag
Author List
Aaron Z. Reyes
Category
Clinical Vignettes
Concept
Beta-Blocker Withdrawal
Concept
Intracranial Hemorrhage
Concept
Rebound Tachycardia
Concept
Rebound Hypertension
Concept
Chronic Beta-Blocker Therapy
Distinguished
Non-Finalist
Presenter Organization
UCSD Health
Presenting Author
Aaron Z. Reyes
Track
Adult
Keywords
intracranial hemorrhage
beta-blocker withdrawal
metoprolol
uterine carcinosarcoma
brain metastasis
peri-procedural management
rebound hypertension
endoscopy
acute anemia
neurocritical care
Beta-Blocker Withdrawal
Intracranial Hemorrhage
Rebound Tachycardia
Rebound Hypertension
Chronic Beta-Blocker Therapy
×
Please select your language
1
English